Investment Thesis
Core Laboratories is fundamentally distressed with negative net profitability, inability to cover interest expenses (0.7x coverage), and stagnant revenue growth of 0.5% YoY. The company generates minimal operating cash flow ($4M on $121.8M revenue) and essentially zero free cash flow, creating acute debt service risk despite moderate leverage ratios. Without significant operational turnaround, the company faces solvency challenges.
Strengths
- Reasonable short-term liquidity with 2.05x current ratio
- Moderate leverage with 0.44x debt-to-equity ratio
- Positive operating cash flow of $4M provides minimal cushion
Risks
- Critical interest coverage of 0.7x - cannot cover debt service from operations
- Negative net income and negative ROE/ROA indicate shareholder value destruction
- Stagnant revenue growth of 0.5% with declining profitability suggests structural headwinds
- Extremely low free cash flow of $517K with $117M long-term debt creates refinancing risk
- Operating margin collapse to 1.5% shows pricing pressure in oil & gas services sector
Key Metrics to Watch
- Interest coverage ratio - must exceed 1.5x to ensure debt sustainability
- Operating cash flow trend - currently insufficient to support debt service
- Revenue growth acceleration - stagnation at 0.5% indicates no recovery trajectory
- Operating margin expansion - must return to positive territory on net basis
Financial Metrics
Revenue
121.8M
Net Income
-789.0K
EPS (Diluted)
$-0.02
Free Cash Flow
517.0K
Total Assets
587.7M
Cash
22.8M
Profitability Ratios
Gross Margin
N/A
Operating Margin
1.5%
Net Margin
-0.6%
ROE
-0.3%
ROA
-0.1%
FCF Margin
0.4%
Balance Sheet & Liquidity
Current Ratio
2.05x
Quick Ratio
1.50x
Debt/Equity
0.44x
Debt/Assets
0.0%
Interest Coverage
0.65x
Long-term Debt
117.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T14:41:27.239072 |
Data as of: 2026-03-31 |
Powered by Claude AI